Financhill
Sell
32

CIM Quote, Financials, Valuation and Earnings

Last price:
$13.37
Seasonality move :
-5.65%
Day range:
$13.29 - $13.63
52-week range:
$9.85 - $14.88
Dividend yield:
7.76%
P/E ratio:
7.62x
P/S ratio:
1.29x
P/B ratio:
0.68x
Volume:
687.1K
Avg. volume:
942.2K
1-year change:
-2.98%
Market cap:
$1.1B
Revenue:
$850.6M
EPS (TTM):
$1.75

CIM Analysts' Consensus Rating

The 5 analysts providing 12-month price projections for Chimera Investment Corp. shares anticipate an average target of $14.83, ranging from a low estimate of $14.00 to a high estimate of $15.50. This average target implies a growth of 11.11% compared to the current stock price of $13.35.

Consensus Price Target

$14.83

Highest Price Target

$15.50

Lowest Price Target

$14.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 1 1 1

Hold 3 4 4

Sell 0 0 0
Consensus Hold Hold Hold

CIM Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.7T
P/E Ratio: 65x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 36x

Sell
48
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
54
ACLX alert for Feb 24

Arcellx, Inc. [ACLX] is up 77.43% over the past day.

Buy
65
RNG alert for Feb 24

RingCentral, Inc. [RNG] is down 12.48% over the past day.

Buy
71
SNSE alert for Feb 24

Sensei Biotherapeutics, Inc. [SNSE] is down 2.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock